AAAAAA

   
Results: 1-13 |
Results: 13
Phase I study of Gliadel (TM) wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas
Authors: Gururangan, S Cokgor, I Rich, JN Edwards, S Affronti, ML Quinn, JA Herndon, JE Provenzale, JM McLendon, RE Tourt-Uhlig, S Sampson, JH Stafford-Fox, V Zaknoen, S Early, M Friedman, AH Friedman, HS
Citation: S. Gururangan et al., Phase I study of Gliadel (TM) wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas, NEURO-ONCOL, 3(4), 2001, pp. 246-250
Long term response in a patient with neoplastic meningitis secondary to melanoma treated with I-131-radiolabeled antichondroitin proteoglycan sulfateMel-14 F(ab ')(2) - A case study
Authors: Cokgor, I Akabani, G Friedman, HS Friedman, AH Zalutsky, MR Zehngebot, LM Provenzale, JM Guy, CD Wikstrand, CJ Bigner, DD
Citation: I. Cokgor et al., Long term response in a patient with neoplastic meningitis secondary to melanoma treated with I-131-radiolabeled antichondroitin proteoglycan sulfateMel-14 F(ab ')(2) - A case study, CANCER, 91(9), 2001, pp. 1809-1813
High frequency wobbles: A write clock generation method for rewritable digital versatile disk (DVD) that enables near drop-in compatibility with DVD-read only memories (DVD-ROMs)
Authors: Abramovitch, D Towner, D Perlov, C Hogan, J Fischer, M Wilson, C Cokgor, I Taussig, C
Citation: D. Abramovitch et al., High frequency wobbles: A write clock generation method for rewritable digital versatile disk (DVD) that enables near drop-in compatibility with DVD-read only memories (DVD-ROMs), JPN J A P 1, 39(2B), 2000, pp. 846-854
Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas
Authors: Cokgor, I Akabani, G Kuan, CT Friedman, HS Friedman, AH Coleman, RE McLendon, RE Bigner, SH Zhao, XG Garcia-Turner, AM Pegram, CN Wikstrand, CJ Shafman, TD Herndon, JE Provenzale, JM Zalutsky, MR Bigner, DD
Citation: I. Cokgor et al., Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas, J CL ONCOL, 18(22), 2000, pp. 3862-3872
Phase I trial of carmustine plus O-6-benzylguanine for patients with recurrent or progressive malignant glioma
Authors: Friedman, HS Pluda, J Quinn, JA Ewesuedo, RB Long, L Friedman, AH Cokgor, I Colvin, OM Haglund, MM Ashley, DM Rich, JN Sampson, J Pegg, AE Moschel, RC McLendon, RE Provenzale, JM Stewart, ES Tourt-Uhlig, S Garcia-Turner, AM Herndon, JE Bigner, DD Dolan, ME
Citation: Hs. Friedman et al., Phase I trial of carmustine plus O-6-benzylguanine for patients with recurrent or progressive malignant glioma, J CL ONCOL, 18(20), 2000, pp. 3522-3528
Dosimetry and dose-response relationships in newly diagnosed patients withmalignant gliomas treated with iodine-131-labeled anti-tenascin monoclonalantibody 81C6 therapy
Authors: Akabani, G Cokgor, I Coleman, RE Trotter, DG Wong, TZ Friedman, HS Friedman, AH Garcia-Turner, A Herndon, JE DeLong, D McLendon, RE Zhao, XG Pegram, CN Provenzale, JM Bigner, DD Zalutsky, MR
Citation: G. Akabani et al., Dosimetry and dose-response relationships in newly diagnosed patients withmalignant gliomas treated with iodine-131-labeled anti-tenascin monoclonalantibody 81C6 therapy, INT J RAD O, 46(4), 2000, pp. 947-958
Chemotherapy for adults with malignant glioma
Authors: Cokgor, I Friedman, HS Friedman, AH
Citation: I. Cokgor et al., Chemotherapy for adults with malignant glioma, CANCER INV, 17(4), 1999, pp. 264-272
Irinotecan therapy in adults with recurrent or progressive malignant glioma
Authors: Friedman, HS Petros, WP Friedman, AH Schaaf, LJ Kerby, T Lawyer, J Parry, M Houghton, PJ Lovell, S Rasheed, K Cloughsey, T Stewart, ES Colvin, OM Provenzale, JM McLendon, RE Bigner, DD Cokgor, I Haglund, M Rich, J Ashley, D Malczyn, J Elfring, GL Miller, LL
Citation: Hs. Friedman et al., Irinotecan therapy in adults with recurrent or progressive malignant glioma, J CL ONCOL, 17(5), 1999, pp. 1516-1525
Monoclonal antibody therapy of human gliomas: Current status and future approaches
Authors: Wikstrand, CJ Cokgor, I Sampson, JH Bigner, DD
Citation: Cj. Wikstrand et al., Monoclonal antibody therapy of human gliomas: Current status and future approaches, CANC METAST, 18(4), 1999, pp. 451-464
Dosimetry of I-131-labeled 81C6 monoclonal antibody administered into surgically created resection cavities in patients with malignant brain tumors
Authors: Akabani, G Reist, CJ Cokgor, I Friedman, AH Friedman, HS Coleman, RE Zhao, XG Bigner, DD Zalutsky, MR
Citation: G. Akabani et al., Dosimetry of I-131-labeled 81C6 monoclonal antibody administered into surgically created resection cavities in patients with malignant brain tumors, J NUCL MED, 40(4), 1999, pp. 631-638
Topotecan treatment of adults with primary malignant glioma
Authors: Friedman, HS Kerby, T Fields, S Zilisch, JE Graden, D McLendon, RE Houghton, PJ Arbuck, S Cokgor, I Friedman, AH
Citation: Hs. Friedman et al., Topotecan treatment of adults with primary malignant glioma, CANCER, 85(5), 1999, pp. 1160-1165
Paediatric update - Gliomas
Authors: Cokgor, I Friedman, AH Friedman, HS
Citation: I. Cokgor et al., Paediatric update - Gliomas, EUR J CANC, 34(12), 1998, pp. 1910-1915
DNA mismatch repair and O-6-alkylguanine-DNA alkyltransferase analysis andresponse to temodal in newly diagnosed malignant glioma
Authors: Friedman, HS McLendon, RE Kerby, T Dugan, M Bigner, SH Henry, AJ Ashley, DM Krischer, J Lovell, S Rasheed, K Marchev, F Seman, AJ Cokgor, I Rich, J Stewart, E Colvin, OM Provenzale, JM Bigner, DD Haglund, MM Friedman, AH Modrich, PL
Citation: Hs. Friedman et al., DNA mismatch repair and O-6-alkylguanine-DNA alkyltransferase analysis andresponse to temodal in newly diagnosed malignant glioma, J CL ONCOL, 16(12), 1998, pp. 3851-3857
Risultati: 1-13 |